Next, we tested whether OVA antigen-expressing Hep55.1c-Tet3G-LucOS tumor cells can be recognized by OT-I CD8+ T cells, which express transgenic TCR-recognizing OVA257-264 peptide-MHC-I complex. The gene discussed is CD8A; the disease is neoplasm.